Correlation of Moderate-Intensity Physical Exercise on Irisin, Oxidized-LDL and HDL Level in ≥50 Years Old Obese Men

Made Putra Semadhi, Melisa Intan Barliana, Dewi Muliaty, Andi Wijaya


BACKGROUND: Irisin is secreted by our muscle during physical exercise, which has been recently studied to be linked with lipid metabolism. The aim of this study was to investigate the role of irisin that interact with the oxidized-low density lipoprotein (ox-LDL) and high density lipoprotein cholesterol (HDL-C) levels that are affected by moderate intensity exercise in obese men aged ≥50 years.

METHODS: This was a cross-sectional study with 70 obese men whose age ≥50 years old as participants. Participants were classified into two groups of men with and without physical exercised, based on American College of Sports Medicine (ACSM). Irisin and ox-LDL plasma levels were analyzed using enzyme-linked immunosorbent assay (ELISA), meanwhile the HDL-C serum level was analyzed using homogenous enzymatic methods.

RESULTS: The result showed an association between the duration of physical exercise per week and irisin level (R=0.584, p<0.01), also between the duration of physical excercise per week and ox-LDL level (R=-0.274, p<0.05). Meanwhile, there was a negative association between irisin levels and ox-LDL (R=-0.294, p<0.05). Irisin indicated to be correlated with HDL-C (R=0.215, p>0.05).

CONCLUSION: Moderate-intensity physical exercise may decrease cardiovascular risk and improve the quality of life among obese subjects aged ≥50 years old, which was indicated by the decrease of ox-LDL and the increase of irisin level. In addition, it can be concluded that the higher the irisin level showed the lower levels of ox-LDL and higher level of HDL-C.

KEYWORDS: obesity, elderly, irisin, ox-LDL, HDL-C, physical exercise

Full Text:



Han TS, Tajar A, Lean MEJ. Obesity and weight management in the elderly. Br Med Bull. 2011; 97: 169-96, CrossRef.

Amarya S, Singh K, Sabharwal M. Health consequences of obesity in the elderly. J Clin Gerontol Geriatr. 2014; 5: 63-7, CrossRef.

McMurray F, Patten DA, Harper ME. Reactive oxygene species and oxidative stress in obesity-recent findings and empirical approach. J Endocrinol. 2016; 24: 2301-10, CrossRef.

Alam I, Ng TP, Larbi A. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm. 2012; 2012: 456456,

Miljkovic N, Lim JY, Miljkovic I, Frontera WR. Aging of skeletal muscle fibers. Annals Rehabilitaion Medic. 2015; 39: 155-62, CrossRef.

Alique M, Luna C, Carracedo J, Ramírez R. LDL biochemical modifications: a link between atherosclerosis and aging. Food Nutr Res. 2015; 59: 29240, CrossRef.

Power SK, Ji LL, Kavazis AN, Jackson MJ. Reactive oxygen species: impact on skeletal muscle. Compr Physiol. 2011; 1: 941-69, CrossRef.

Esfahani M, Baranchi M, Goodarzi MT. Irisin and metabolic disorders. Avicenna J Med Biotechnol. 2016; 4 : e33230, CrossRef.

Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98: E769-78, CrossRef.

Zügel M, Qiu S, Laszlo R, Bosnyák E, Weigt C, Müller D, et al. The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion. J Endocrinol. 2016; 54: 101-10, CrossRef.

Gao S, Li F, Li H, Huang Y, Liu Y, Chen Y. Effects and molecular mechanism of GST-irisin on lipolysis and autocrine function in 3T3-L1 adipocytes. PLoS One. 2016: 11, e0147480, CrossRef.

Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nature Rev Endocrinology. 2017; 13: 324-37, CrossRef.

Wu J, Spiegelman BM. Irisin ERKs the fat. Diabetes. 2014; 63: 381-3, CrossRef.

Schulz TJ, Tseng YH. Brown adipose tissue: development, metabolism and beyond. Biochemistry. 2013; 453 :167-78, CrossRef.

Dillon LM, Rebelo AP, Moraes CT. The role of PGC-1 coactivators in aging skeletal muscle and heart. IUBMB Life . 2012; 64 :231-41, CrossRef.

Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012; 61 : 1725-38, CrossRef.

Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014; 281: 739-49, CrossRef.

Zhao J, Su Z, Qu C, Dong Y. Effects of 12 weeks resistance training on serum irisin in older male adults. Front Physiol. 2017; 8: 171, CrossRef.

Cavalier É, Mismetti V, Souberbielle JC. Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose. Annal Endocrinol. 2014; 75: 162-4, CrossRef.

Kim HJ, Lee HJ, So B, Son JS, Yoon D, Song W. Effect of aerobic training and resistance training on circulating irisin level and their association with change of body composition in overweight/obese adults: a pilot study. Physiol Res. 2016; 65: 271-9, PMID.

Löffler, D, Müller U, Scheuermann K, Friebe D, Gesing J, Bielitz J, et al. Serum irisin levels are regulated by acute strenuous exercise. Journal of Clinical Endocrinology. Metabolism. 2015; 100: 1289-99, CrossRef.

Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481: 463-8, CrossRef.

Zhou Q, Chen K, Liu P, Gao Y, Zou D, Deng H, et al. Dihydromyricetin stimulates irisin secretion partially via the PGC-1α pathway. Mol Cell Endocrinol. 2015; 412: 349-57, CrossRef.

Wang Y, Xu D. Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 2017; 16: 132, CrossRef.

Sponder M, Campean IA, Dalos D, Emich M, Fritzer-Szekeres M, Litschauer B, et al. Effect of long-term physical activity on PCSK9, high- and low-density lipoprotein cholesterol, and lipoprotein(a) levels: a prospective observational trial. Pol Arch Intern Med. 2017; 127: 506-11, CrossRef.

Holvoet P, De Keyzer D, Jacobs Jr DR. Oxidized LDL and the metabolic syndrome. Future Lipidol. 2008; 3: 637-49, CrossRef.

Dimayuga PC, Zhao X, Yano J, Chyu KY. Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(−/−) mice. Am J Physiol Regul Integr Comp Physiol. 2006; 291: R1644-50, CrossRef.

Tang H, Yu R, Liu S, Huwatibieke B, Li Z, Zhang W. Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2 signaling. EBioMedicine. 2016; 6: 139-48, CrossRef.

Zhang Y, Mu Q, Zhou Z, Song H, Zhang Y, Wu F, et al. Protective effect of irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction. PLoS One. 2016; 11: e0158038, CrossRef.


Copyright (c) 2019 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute